• One Health
  • Pain Management
  • Oncology
  • Anesthesia
  • Geriatric & Palliative Medicine
  • Ophthalmology
  • Anatomic Pathology
  • Poultry Medicine
  • Infectious Diseases
  • Dermatology
  • Theriogenology
  • Nutrition
  • Animal Welfare
  • Radiology
  • Internal Medicine
  • Small Ruminant
  • Cardiology
  • Dentistry
  • Feline Medicine
  • Soft Tissue Surgery
  • Urology/Nephrology
  • Avian & Exotic
  • Preventive Medicine
  • Anesthesiology & Pain Management
  • Integrative & Holistic Medicine
  • Food Animals
  • Behavior
  • Zoo Medicine
  • Toxicology
  • Orthopedics
  • Emergency & Critical Care
  • Equine Medicine
  • Pharmacology
  • Pediatrics
  • Respiratory Medicine
  • Shelter Medicine
  • Parasitology
  • Clinical Pathology
  • Virtual Care
  • Rehabilitation
  • Epidemiology
  • Fish Medicine
  • Diabetes
  • Livestock
  • Endocrinology

Dealing with dysrexia


In this CE webinar, gain a greater understanding of the various causes and potentially serious clinical impact of dysrexia. Also learn about the available treatment options for stimulating appetite in affected dogs.

In this 1-hour webinar, you will gain a greater understanding of dysrexia, its various causes and clinical impact on dogs, as well as the available treatment options for appetite stimulation. 

Learn more about addressing dysrexia in your canine patients by attending this free CE webinar.

Now available on demand!

(Original presentation: September 13, 2018)

Presented by:


CE credit:*

1.00 hour

Approximate presentation length:

1 hour

Click here to register for this webinar!

Presentation Topics:

In this 1-hour webinar, presented by Vetsymposium and Aratana Therapuetics, Dr. Audrey Cook provides an overview of dysrexia (a distortion of normal appetite or eating patterns) and the specific causes and consequences from a clinical and quality of life perspective.

You will learn about:

The regulation of appetite and the role of ghrelin in appetite stimulation

The available therapeutic options for treating dogs with dysrexia

The efficacy and safety studies that supported the FDA-approval of capromorelin as an appetite stimulant

The protocol Dr. Cook and her team uses for treating various canine patients with dysrexia

Register now!

Sponsored by Aratana Therapeutics




*This program 1112-34127 is approved by the AAVSB RACE to offer a total of 1.00 CE credits (1.00 max) being available to any one Veterinarian and/or 1.00 Veterinary Technician CE credits (1.00 max). This RACE approval is for the subject matter categories of: Category Two: Non-Scientific-Clinical using the delivery method of Interactive-Distance. This approval is valid in jurisdictions that recognize AAVSB RACE; however, participants are responsible for ascertaining each board's CE requirements. RACE does not "accredit" or "endorse" or "certify" any program or person, nor does RACE approval validate the content of the program. RACE provider #1112.

© 2024 MJH Life Sciences

All rights reserved.